R Holden, M A Jackson. Show Affiliations »
Abstract
Entities: Chemical Disease Gene
Mesh: See more » 3,4-Methylenedioxyamphetamine/adverse effectsAdultComa/chemically inducedHallucinogens/adverse effectsHumansHyponatremia/chemically inducedMaleSerotonin Agents/adverse effectsVasopressins/metabolism
Substances: See more » HallucinogensSerotonin AgentsVasopressins3,4-Methylenedioxyamphetamine
Year: 1996 PMID: 8606600 DOI: 10.1016/s0140-6736(96)90196-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321